Stephanie Dorman

Stephanie Dorman, PhD, is the Early-Stage Global Medical Strategy Lead at Pfizer, a role they have held since 2023. Previously, Stephanie was a Global Medical Director focusing on Acute Leukemia and Biosimilars at Pfizer and served as a US Medical Director in Leukemia. They conducted molecular biology research as a Visiting Scientist at both MiNA Therapeutics and Apterna Ltd. Stephanie earned a Doctor of Philosophy in Biochemistry from The University of Western Ontario, where they also completed a Bachelor of Medical Sciences and a degree from the Richard Ivey School of Business.